5
total announcements
BALAXI.NS · 15 min delayed
BALAXI PHARMACEUTICALS LIMITED
Balaxi Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication regarding the 83rd Annual General Meeting to be held on 24th August, 2026, through Video Conferencing/OAVM and e-voting.
BALAXI PHARMACEUTICALS LIMITED
Balaxi Pharmaceuticals Limited has clarified discrepancies in its financial results for the quarter ended March 31, 2026, correcting errors in employee benefit expense and other comprehensive income in the standalone and consolidated XBRL filings.
BALAXI PHARMACEUTICALS LIMITED
Balaxi Pharmaceuticals has informed the Exchange regarding the re-lodgement of transfer requests of physical shares for the period ended June 2026, as per SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 dated 30th January, 2026.
BALAXI PHARMACEUTICALS LIMITED
Balaxi Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with dematerialization of securities for the quarter ended 30th June, 2026.
BALAXI PHARMACEUTICALS LIMITED
Balaxi Pharmaceuticals Limited has informed the Exchange regarding the closure of the trading window for insiders due to the upcoming declaration of unaudited financial results for the quarter ending 30th June, 2026.